HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stellettin A induces oxidative stress and apoptosis in HL-60 human leukemia and LNCaP prostate cancer cell lines.

Abstract
The present study has demonstrated a differential cytotoxicity of stellettin A (1) between human leukemia HL-60 cells (IC50 0.4 microg/mL) and human prostate cancer LNCaP cells (IC50 120 microg/mL). Treatment of cells with 1 revealed the activation of NADPH oxidase, the dramatic generation of reactive oxygen species, and the dissipation of mitochondrial membrane potentials, with HL-60 cells being more sensitive than LNCaP cells by an order of magnitude. Immunoblotting analysis further demonstrated a stronger upregulation of the apoptosis marker proteins, FasL and caspase-3, in HL-60 cells, and pretreatment of cells with antisense oligonucleotide for caspase-3 abolished apoptosis. All available evidence suggests that 1 induces oxidative cell death through a FasL-caspase-3-apoptotic pathway.
AuthorsW K Liu, F W K Cheung, Chun-Tao Che
JournalJournal of natural products (J Nat Prod) Vol. 69 Issue 6 Pg. 934-7 (Jun 2006) ISSN: 0163-3864 [Print] United States
PMID16792413 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • FASLG protein, human
  • Fas Ligand Protein
  • Membrane Glycoproteins
  • Triterpenes
  • Tumor Necrosis Factors
  • stellettin A
  • CASP3 protein, human
  • Caspase 3
  • Caspases
Topics
  • Animals
  • Apoptosis (drug effects)
  • Caspase 3
  • Caspases (metabolism)
  • Fas Ligand Protein
  • HL-60 Cells
  • Humans
  • Male
  • Membrane Glycoproteins (metabolism)
  • Membrane Potentials
  • Mitochondria (physiology)
  • Oxidative Stress (drug effects)
  • Porifera (chemistry)
  • Prostatic Neoplasms (metabolism)
  • Triterpenes (chemistry, isolation & purification, pharmacology)
  • Tumor Cells, Cultured
  • Tumor Necrosis Factors (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: